| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
83,754,000 |
| Market
Cap: |
1.73(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$7.58 - $23.53 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kura Oncology is a clinical-stage biopharmaceutical company engaged in developing medicines for the treatment of cancer. Co.'s primary product candidate, ziftomenib, is a selective, reversible and oral small molecule inhibitor which blocks the interaction of two proteins, menin and the protein expressed by the Lysine K-specific Methyl Transferase 2A gene. Co.'s second product candidate, tipifarnib, is a selective and orally bioavailable inhibitor of farnesyl transferase. Co. is evaluating tipifarnib in multiple solid tumor and hematologic indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
50,000 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$575,000 |
$575,000 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
108,902 |
108,902 |
125,502 |
| Total Sell Value |
$0 |
$2,177,814 |
$2,177,814 |
$2,411,082 |
| Total People Sold |
0 |
5 |
5 |
6 |
| Total Sell Transactions |
0 |
6 |
6 |
11 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wilson Troy Edward |
President and CEO |
• • – |
2020-08-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
26,041 |
1,795,017 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
26,041 |
28,096 |
|
- |
|
| Grasso Marc |
CFO, CBO |
• – – |
2020-08-07 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
0 |
|
82% |
|
| Grasso Marc |
CFO, CBO |
• – – |
2020-08-07 |
4 |
OE |
$15.47 |
$109,868 |
D/D |
7,102 |
10,000 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-02-11 |
4 |
OE |
$4.80 |
$136,461 |
D/D |
28,096 |
54,137 |
|
- |
|
| Gualberto Antonio |
Head of Development & CMO |
• – – |
2019-07-10 |
4 |
AS |
$21.11 |
$379,903 |
D/D |
(18,000) |
339,973 |
|
- |
|
| Gualberto Antonio |
Head of Development & CMO |
• – – |
2019-07-10 |
4 |
OE |
$6.15 |
$110,700 |
D/D |
18,000 |
357,973 |
|
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-21 |
4 |
B |
$13.16 |
$1,099,386 |
D/D |
83,540 |
4,408,097 |
2.45 |
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-19 |
4 |
B |
$13.84 |
$718,005 |
D/D |
51,879 |
4,324,557 |
2.45 |
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-18 |
4 |
B |
$13.82 |
$1,084,442 |
D/D |
78,469 |
4,272,678 |
2.45 |
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-17 |
4 |
S |
$13.20 |
$350,064 |
D/D |
(26,520) |
4,194,209 |
|
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-13 |
4 |
B |
$13.89 |
$350,264 |
D/D |
25,217 |
4,220,729 |
2.45 |
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-11 |
4 |
B |
$13.91 |
$213,098 |
D/D |
15,321 |
4,195,512 |
2.45 |
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-06 |
4 |
B |
$13.49 |
$230,396 |
D/D |
17,079 |
4,180,919 |
2.45 |
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-04 |
4 |
B |
$13.08 |
$714,757 |
D/D |
54,645 |
4,163,112 |
2.45 |
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2018-12-03 |
4 |
B |
$13.97 |
$673,103 |
D/D |
48,182 |
4,108,467 |
2.45 |
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2018-11-06 |
4 |
OE |
$4.80 |
$124,997 |
D/D |
26,041 |
59,026 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2017-08-22 |
4 |
OE |
$4.80 |
$134,328 |
D/D |
27,985 |
32,985 |
|
- |
|
| Ecor1 Capital Fund Qualified, L.p. |
10% Owner |
– – • |
2017-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,057,191 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • • |
2017-04-21 |
4 |
OE |
$4.80 |
$24,000 |
D/D |
5,000 |
5,000 |
|
- |
|
| Henson Heidi |
Chief Financial Officer |
• – – |
2016-12-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,596 |
245,000 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2016-12-05 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
1,735,991 |
|
- |
|
| Henson Heidi |
Chief Financial Officer |
• – – |
2015-11-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
247,596 |
|
- |
|
| Malley Thomas |
Director |
– • – |
2015-11-10 |
4 |
B |
$8.00 |
$400,000 |
I/I |
50,000 |
89,557 |
2.1 |
- |
|
| Malley Thomas |
Director |
– • – |
2015-10-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
39,557 |
|
- |
|
115 Records found
|
|
Page 4 of 5 |
|
|
0.06 (0.29%) 
